InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by KATZAROFF JAMES C. Director active across 2 companies, notably GlobeStar Therapeutics Corp. Aggregated, 3 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €9k. Activity tracked since 3 April 2023. The latest transaction was filed on 28 August 2023 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations